Nefazodone and depression. 1998

W V Vieweg
Department of Psychiatry, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298-0710, USA.

Nefazodone is a fourth-generation antidepressant with novel serotonergic actions. It is a potent antagonist of synaptic 5-HT(2) receptors and a moderate blocker of synaptic 5-HT reuptake. Its mild synaptic blockade of norepinephrine is of little clinical importance. Besides its effectiveness in depression, nefazodone is effective in depression-related anxiety. Of all the antidepressants, nefazodone is least likely to induce sexual dysfunction. This drug increases sleep efficiency and reduces the number of nighttime awakenings. Nefazodone, compared with many other antidepressants, is unlikely to induce a withdrawal syndrome if abruptly stopped.

UI MeSH Term Description Entries

Related Publications

W V Vieweg
April 1995, The Medical letter on drugs and therapeutics,
W V Vieweg
October 1996, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
W V Vieweg
October 2000, The New England journal of medicine,
W V Vieweg
October 2000, The New England journal of medicine,
W V Vieweg
October 2000, The New England journal of medicine,
W V Vieweg
October 2000, The New England journal of medicine,
W V Vieweg
January 2002, The Journal of clinical psychiatry,
W V Vieweg
January 1994, Psychopharmacology bulletin,
W V Vieweg
May 2005, Archives of women's mental health,
W V Vieweg
April 1998, Journal of clinical psychopharmacology,
Copied contents to your clipboard!